PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40122C00152Service contract for a SEQUEL 2e — Pacific Biosciences of California, Inc

Pacific Biosciences of California, Inc holds $7.8M across 81 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Sep 19, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
Pacific Biosciences of California, Inc
Recipient
Sep 19, 2026
PoP end
$189K
Obligated
$315K
Potential
811219
NAICS
J066
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Pacific Biosciences of California, Inc — $90

Contract facts

NONE
Contract number75F40122C00152
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentPacific Biosciences of California, Inc
CAGE49H66
UEICP22V46XYQK6
NAICS811219

No full NAICS 811219 intel page yet. Browse NAICS intelligence

PSCJ066
Place of performanceCOLLEGE PARK MD
Pricing typeFirm Fixed Price
Extent competedNot Competed
Related solicitation75F40122R00080
PoP startSep 20, 2022
PoP end (current)Sep 19, 2026
PoP end (w/ options)Sep 19, 2027
Obligated$189K
Current value$246K
Potential value$315K

SERVICE CONTRACT FOR A SEQUEL 2E LONG-READ SEQUENCER is a federal NONE award for Fda Office Of Acq Grant Svcs held by Pacific Biosciences of California, Inc. Estimated value $315K ($189K obligated). Current period of performance ends Sep 19, 2026 (potential Sep 19, 2027). Last award drew 1 bidder. Place of performance: COLLEGE PARK MD. Related solicitation 75F40122R00080.

SERVICE CONTRACT FOR A SEQUEL 2E LONG-READ SEQUENCER

Recompete timing

Public
Expiring in 29 days

Current PoP ends Sep 19, 2026 (29 days remaining). Agencies typically plan 12–18 months ahead — at 1.0 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Pacific Biosciences of California, Inc$7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($7.8M) · all agencies
Department of Health and Human Services (HHS)$5.3M · 68%Department of Agriculture (USDA)$2.3M · 29%Department of Defense (DOD)$197K · 3%
Open full company profile

Related awards

Same incumbent
75N92025P00381
REVIO SMRT CELLS AND SEQUENCING REAGENTS - NEW AWARD
$198K
Sep 26, 2026
1232SA26F0221
LONG-READ SEQUENCING REAGENTS OF WHOLE GENOME ANALYSES
$240K
Sep 30, 2026
1232SA25F0277
PACBIO REAGENT KITS. ALL REAGENTS FOR SEQUENCING 24 REVIO SMRT CELLS QUANTITY 8, AND ASSOC…
$233K
Sep 30, 2026
75F40121P00562
VERSATILE SEQUENCING II SYSTEM
$483K
Nov 16, 2026
75N98026P00928
NHGRI: SUPPLY: SEQUENCING REAGENTS: N/A
$347K
Jul 7, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40122C00152?

75F40122C00152 (Service contract for a SEQUEL 2e) is a Fda Office Of Acq Grant Svcs award with a potential value of $315K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40122C00152?

Fda Office Of Acq Grant Svcs awarded 75F40122C00152 to Pacific Biosciences of California, Inc (potential $315K).

Who is the incumbent on 75F40122C00152?

Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Sep 19, 2026.

When does Pacific Biosciences of California, Inc’s 75F40122C00152 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 19, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40122C00152